Genomics

Dataset Information

0

EGAS00001000415-sc-2019-08-21T10:34:41Z - samples

ABSTRACT: We have collected material from a patient who had BrafV600E mutant melanoma that was treated with PLX4032. We have germline DNA from the patient and DNA and RNA from distinct lesions before and after treatment with PLX4032. We would like to exome sequence these samples to gain a snap shot of the mechanisms of resistance that are operative. . This dataset contains all the data available for this study on 2019-08-21.

PROVIDER: EGAD00001005278 | EGA |

REPOSITORIES: EGA

Json Xml
altmetric image

Publications

The development of targeted inhibitors, like vemurafenib, has greatly improved the clinical outcome of BRAF(V600E) metastatic melanoma. However, resistance to such compounds represents a formidable problem. Using whole-exome sequencing and functional analyses, we have investigated the nature and pleiotropy of vemurafenib resistance in a melanoma patient carrying multiple drug-resistant metastases. Resistance was caused by a plethora of mechanisms, all of which reactivated the MAPK pathway. In ad  ...[more]

Similar Datasets

Transcriptomics The Transcriptome of PLX4032 resistance
2013-06-07 | E-ERAD-138 | biostudies-arrayexpress
Genomics EGAS00001000413-sc-20130606 - samples
| EGAD00001000599 | EGA
Genomics The Transcriptome of PLX4032 resistance
| EGAS00001000413 | EGA
Genomics Analysis of resistance to PLX4032
| EGAS00001000415 | EGA
Genomics EGAS00001000097-sc-2019-08-21T10:34:54Z - samples
| EGAD00001005273 | EGA
Genomics
| PRJEB27976 | ENA
Genomics Genomic Snap-Shot of Staphylococcus aureus Bactereamia in Australia
| PRJEB22792 | ENA
Genomics EGAS00001000352-sc-2019-08-21T10:33:56Z - samples
| EGAD00001005276 | EGA
Genomics EGAS00001000308-sc-2019-08-21T10:35:19Z - samples
| EGAD00001005275 | EGA
Genomics EGAS00001000098-sc-2019-08-21T10:35:07Z - samples
| EGAD00001005274 | EGA